Assessing the clinical safety and anti-tumor efficacy of ProAgio, a rationally designed protein cytotoxin
From Video Conferencing
views
Skip to main content
- Home
- Channels
- All Recordings
- Archived
- Employees
-
Grand Rounds
- Advanced Practice Providers
- Center for Genomic Medicine
- Dartmouth Cancer Center
- Dermatology
- Heart and Vascular Center
- HIV and AIDS Seminars
- Informatics
- Leadership Preventative Medicine
- Medicine
- Neurology
- Nursing
- OB/GYN
- Orthopaedics
- Pediatric
- Primary Care and Population Health
- Psychiatry Grand Rounds
- Surgery
- Value Grand Rounds
- Healthcare Professionals
- Live Broadcasts
- Patients
- Research & Innovation
- Channels
- Live Broadcasts
- Home
- Channels
- All Recordings
- Archived
- Employees
-
Grand Rounds
- Advanced Practice Providers
- Center for Genomic Medicine
- Dartmouth Cancer Center
- Dermatology
- Heart and Vascular Center
- HIV and AIDS Seminars
- Informatics
- Leadership Preventative Medicine
- Medicine
- Neurology
- Nursing
- OB/GYN
- Orthopaedics
- Pediatric
- Primary Care and Population Health
- Psychiatry Grand Rounds
- Surgery
- Value Grand Rounds
- Healthcare Professionals
- Live Broadcasts
- Patients
- Research & Innovation
- Channels
- Live Broadcasts